These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 24556694)
1. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways. Cheng J; Fan YH; Xu X; Zhang H; Dou J; Tang Y; Zhong X; Rojas Y; Yu Y; Zhao Y; Vasudevan SA; Zhang H; Nuchtern JG; Kim ES; Chen X; Lu F; Yang J Cell Death Dis; 2014 Feb; 5(2):e1079. PubMed ID: 24556694 [TBL] [Abstract][Full Text] [Related]
2. Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma. Lu J; Guan S; Zhao Y; Yu Y; Wang Y; Shi Y; Mao X; Yang KL; Sun W; Xu X; Yi JS; Yang T; Yang J; Nuchtern JG Oncotarget; 2016 Dec; 7(50):82757-82769. PubMed ID: 27764791 [TBL] [Abstract][Full Text] [Related]
3. The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model. Lu J; Guan S; Zhao Y; Yu Y; Woodfield SE; Zhang H; Yang KL; Bieerkehazhi S; Qi L; Li X; Gu J; Xu X; Jin J; Muscal JA; Yang T; Xu GT; Yang J Cancer Lett; 2017 Aug; 400():61-68. PubMed ID: 28455243 [TBL] [Abstract][Full Text] [Related]
4. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis. Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231 [TBL] [Abstract][Full Text] [Related]
5. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis. Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807 [TBL] [Abstract][Full Text] [Related]
8. Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis. Chen Z; Wang L; Yao D; Yang T; Cao WM; Dou J; Pang JC; Guan S; Zhang H; Yu Y; Zhao Y; Wang Y; Xu X; Shi Y; Patel R; Zhang H; Vasudevan SA; Liu S; Yang J; Nuchtern JG Sci Rep; 2016 Dec; 6():38011. PubMed ID: 27991505 [TBL] [Abstract][Full Text] [Related]
9. New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK. Di Paolo D; Yang D; Pastorino F; Emionite L; Cilli M; Daga A; Destafanis E; Di Fiore A; Piaggio F; Brignole C; Xu X; Liang C; Gibbons J; Ponzoni M; Perri P Oncotarget; 2015 Oct; 6(30):28774-89. PubMed ID: 26299615 [TBL] [Abstract][Full Text] [Related]
10. Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro. Singh RK; Dorf L; DeMartino A; Illenye S; Koto K; Currier EA; Ashikaga T; Kim KK; Brard L; Sholler GL Cancer Biol Ther; 2011 Jun; 11(12):1036-45. PubMed ID: 21532338 [TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling. Li H; Yu Y; Zhao Y; Wu D; Yu X; Lu J; Chen Z; Zhang H; Hu Y; Zhai Y; Su J; Aheman A; De Las Casas A; Jin J; Xu X; Shi Z; Woodfield SE; Vasudevan SA; Agarwal S; Yan Y; Yang J; Foster JH Cancer Lett; 2019 Aug; 457():129-141. PubMed ID: 31100410 [TBL] [Abstract][Full Text] [Related]
12. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Chen Z; Wang Z; Pang JC; Yu Y; Bieerkehazhi S; Lu J; Hu T; Zhao Y; Xu X; Zhang H; Yi JS; Liu S; Yang J Sci Rep; 2016 Jul; 6():29090. PubMed ID: 27378523 [TBL] [Abstract][Full Text] [Related]
13. The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma. Maser T; Zagorski J; Kelly S; Ostrander A; Goodyke A; Nagulapally A; Bond J; Park Y; Saulnier Sholler G Cancer Med; 2020 Nov; 9(21):8144-8158. PubMed ID: 33034426 [TBL] [Abstract][Full Text] [Related]
14. Al-Ghabkari A; Narendran A Cancer Biother Radiopharm; 2019 May; 34(4):252-257. PubMed ID: 30724592 [No Abstract] [Full Text] [Related]
15. Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics. Muthu M; Cheriyan VT; Munie S; Levi E; Frank J; Ashour AE; Singh M; Rishi AK PLoS One; 2014; 9(7):e102567. PubMed ID: 25033461 [TBL] [Abstract][Full Text] [Related]
16. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo. Geng X; Xie L; Xing H Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681 [TBL] [Abstract][Full Text] [Related]
17. The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention. Peirce SK; Findley HW; Prince C; Dasgupta A; Cooper T; Durden DL Cancer Chemother Pharmacol; 2011 Aug; 68(2):325-35. PubMed ID: 20972874 [TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway. Luo P; Lin M; Li L; Yang B; He Q PLoS One; 2011; 6(11):e27298. PubMed ID: 22087283 [TBL] [Abstract][Full Text] [Related]
19. p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy. Moreno-Smith M; Lakoma A; Chen Z; Tao L; Scorsone KA; Schild L; Aviles-Padilla K; Nikzad R; Zhang Y; Chakraborty R; Molenaar JJ; Vasudevan SA; Sheehan V; Kim ES; Paust S; Shohet JM; Barbieri E Clin Cancer Res; 2017 Nov; 23(21):6629-6639. PubMed ID: 28821555 [No Abstract] [Full Text] [Related]
20. Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro. Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]